Right now, a mother and a father are about to learn that their young child has been diagnosed with cancer. Over the coming months, this family will come to learn a great deal about pediatric cancer. They will learn that their daughter has only a 45% chance of survival. They will learn that pediatric cancer research is grossly underfunded by the government, and represents too small a market to attract private investors.
Sadly, between 1% to 2% of the money donated to most large cancer-based charities is dedicated to pediatric cancer. The family will learn all of this, and more, over the weeks, months, and perhaps years to come – but for the moment they only know that their daughter is very, very sick.
When a child anywhere in the country is diagnosed with neuroblastoma (NB), that child will, in all likelihood, be treated with protocols developed by doctors on KCRF’s medical advisory board.
Those who study neuroblastoma and other pediatric cancers are members of an elite research community. It was a team of pediatric oncologists who, despite being grossly underfunded, achieved the first significant cure rate (80%) for Acute Lymphoblastic Leukemia (ALL) in 1968.
Pediatric cancer researchers have been responsible for introducing some of the most significant treatment protocols in the fight against all cancers, and they have done so on a shoestring budget. They have developed a multi-disciplinarily treatment approach, which utilizes the optimum orchestration of chemotherapy, radiation and surgery.
Doctors have begun to use multiple drugs and collaborate with hospitals all over the world to discover the best treatment plans. Yet prevention is the most effective way to fight disease. This is the absolute domain of pediatricians and pediatric researchers. Many cancers take decades to evolve, and many begin their development in the early, formative years of an adult.
Doctors are able to intervene sooner as we learn more about pediatric cancer. The best example of this is the new vaccine recently introduced that is administered to teenage girls to prevent cervical cancer. This research will benefit all of society. There are no other areas in cancer research where your donations will have a greater significance.
Our Medical Advisory Board
The KCRF medical advisory board is made up of some the top pediatric oncologist from some of the most prestigious medical centers in the United States, including Memorial Sloan-Kettering in New York, Texas Children’s Hospital – Baylor, and Children’s Hospital Los Angeles. We depend on these doctors to identify the most promising pediatric cancer research and clinical trials. The medical advisory board helps define where KCRF funnels the financial resources from donations into the projects that have the greatest potential for finding a cure.
There is a tremendous amount of hope. This is because the doctors fighting for a cure are brilliant, compassionate and gifted. They have dedicated their lives to saving our children. They just need our assistance.